Quantcast

Latest UCLA's Jonsson Comprehensive Cancer Center Stories

2009-11-18 15:41:57

New method may help improve diagnosis, prognosis and treatment monitoring Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. These cells, known as circulating tumor cells, or CTCs, can provide critical information for examining and diagnosing cancer metastasis, determining patient prognosis, and monitoring the effectiveness of therapies. Metastasis...

2009-11-10 18:23:06

The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. The drug, when paired with a chemotherapy regimen, was even more effective in fighting ovarian cancer in cell lines in which signaling of the Src family kinases, associated with the deadly...

2009-10-09 14:52:00

SEATTLE, Oct. 9 /PRNewswire/ -- Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer. The grants establish Seattle as a national hub for conducting such research, which aims to objectively analyze cancer diagnostic tools, screening...

2009-08-20 08:00:00

National Cancer Institute Chemical Biology Consortium to coordinate academic, private and government cancer drug discovery efforts BIRMINGHAM, Ala., Aug. 20 /PRNewswire-USNewswire/ -- Southern Research Institute today announced that it has been selected as one of 11 organizations to help establish the National Cancer Institute's (NCI) Chemical Biology Consortium (CBC)--a program meant to coordinate and accelerate the discovery and development of new therapeutic agents to treat cancer...

2009-07-08 13:12:26

A new finding reveals that African-American patients with breast, ovarian, and prostate cancer tend to die earlier than patients of other races with these cancers, even when they receive identical medical treatment and when socioeconomic factors are controlled for. The finding, an analysis of almost 20,000 patient records from 35 clinical trials, points to biological or genetic factors as the potential source of the survival gap. Dawn Hershman, M.D, M.S., a Columbia University Medical Center...

2009-06-16 08:38:44

Researchers at UCLA's Jonsson Comprehensive Cancer Center, on a quest to find lung cancer stem cells, have developed a unique model to allow further investigation into the cells that many believe may be at the root of all lung cancers.If researchers could find a way to isolate and grow lung cancer stem cells, they could study their biologic mechanisms and perhaps identify targets for new therapies, said Raj Batra, an associate professor of medicine and a Jonsson Cancer Center scientist."What...

2009-04-23 04:00:00

FREMONT, Calif., April 23 /PRNewswire/ -- After a review of several vendors, the University of California Los Angeles (UCLA) has selected the services of Velos and its flagship product, Velos eResearch. The clinical research management system is being implemented at UCLA's Jonsson Comprehensive Cancer Center and an affiliated clinical research network, Translational Oncology Research International, (TORI). Plans are in place to deploy the system in non-cancer studies being conducted in the...

2009-04-15 08:22:58

Findings will allow oncologists to discontinue therapies that aren't effectiveOncologists often have to wait months before they can determine whether a treatment is working. Now, using a non-invasive method, researchers at UCLA's Jonsson Comprehensive Cancer Center have shown that they can determine after a single cycle of chemotherapy whether the toxic drugs are killing the cancer or not.Using a combination Positron Emission Tomography (PET) and computed tomography (CT) scanner, researchers...

2009-04-10 15:36:38

A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. Chemists and biologists at UCLA and colleagues at several other institutions, including Memorial Sloan-Kettering Cancer Center, have created a new drug to treat a particularly lethal form of the disease, known as castration-resistant prostate cancer, or CRPC. Also referred to as hormone-refractory prostate cancer, CRPC is...

2009-02-18 12:16:54

A meta-analysis by Dutch researchers found cancer survivors -- especially women -- have a greater risk of unemployment. Angela G. E. M. de Boer of the Coronel Institute of Occupational Health at the Academic Medical Center in Amsterdam and colleagues conducted a meta-analysis to determine the risk and factors associated with unemployment among adult cancer survivors compared with healthy control participants. The authors identified 26 articles reporting results from 36 studies meeting...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related